Voyageur Pharmaceuticals (CVE:VM) Stock Price Up 21.8% - Should You Buy?

Shares of Voyageur Pharmaceuticals Ltd. (CVE:VM - Get Free Report) rose 21.8% during mid-day trading on Friday . The stock traded as high as C$0.36 and last traded at C$0.34. Approximately 737,132 shares changed hands during trading, an increase of 280% from the average daily volume of 194,201 shares. The stock had previously closed at C$0.28.

Voyageur Pharmaceuticals Stock Up 21.8%

The company has a market cap of C$50.76 million, a price-to-earnings ratio of -31.33 and a beta of 0.32. The company has a current ratio of 0.10, a quick ratio of 0.84 and a debt-to-equity ratio of 4.23. The stock has a 50-day simple moving average of C$0.19 and a 200-day simple moving average of C$0.16.

About Voyageur Pharmaceuticals

Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.